News Releases
New Influenza Vaccine from Sanofi Pasteur Now Licensed by FDA
Sanofi Pasteur, the vaccines division of Sanofi announced today that the US Food and Drug Administration has approved the supplemental biologics license application (sBLA) for licensure of its four-strain influenza vaccine, Fluzone Quadrivalent vaccine.
Intercell Announces Pediatric Approval of its Japanese Encephalitis Vaccine in the US
Intercell AG announced today that the pediatric indication for IXIARO ® , a vaccine to protect against Japanese encephalitis (JE), was approved by the US Food and Drug Administration (FDA).
Facts on Respiratory Syncytial Virus (RSV)
Respiratory syncytial virus (RSV) is a very common virus that leads to mild, cold-like symptoms in adults and older healthy children. But it can be far more serious in infants and toddlers, especially those in certain high-risk groups.
FDA Approves Intelence
Janssen Therapeutics, Division of Janssen Products, LP, announced the U.S. Food and Drug Administration (FDA) has approved INTELENCE ® ( etravirine ) to be administered in combination with other antiretroviral ( ARV ) medications.